Trial Outcomes & Findings for Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants (NCT NCT01819064)
NCT ID: NCT01819064
Last Updated: 2023-04-06
Results Overview
incidence of bradycardia or other arrhythmias
Recruitment status
COMPLETED
Study phase
PHASE4
Target enrollment
60 participants
Primary outcome timeframe
five minutes
Results posted on
2023-04-06
Participant Flow
Participant milestones
| Measure |
Children Weighing Less Than 15Kg
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
Atropine: IV dose at 5 mcg/kg
|
|---|---|
|
Overall Study
STARTED
|
60
|
|
Overall Study
COMPLETED
|
60
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Heart Rate Response to Atropine Doses Less Than 0.1mg IV to Anesthetized Infants
Baseline characteristics by cohort
| Measure |
Children Less Than 15Kg.
n=60 Participants
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure, and weighed less than 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
|
|---|---|
|
Age, Categorical
<=18 years
|
60 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
6.5 months
n=5 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
50 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
60 participants
n=5 Participants
|
|
weight
|
8.1 kilograms
n=5 Participants
|
PRIMARY outcome
Timeframe: five minutesPopulation: There was no restriction on enrollment so long as the child was \<15 kg.
incidence of bradycardia or other arrhythmias
Outcome measures
| Measure |
Children Less Than 5Kg.
n=9 Participants
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure, and weighed less than 5Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
|
Children Weighing 5Kg to 15Kg
n=51 Participants
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure, and weighed between 5Kg and 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
|
|---|---|---|
|
Incidence of Bradycardia
|
0 participants
|
0 participants
|
Adverse Events
Children Less Than 15Kg.
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Children Less Than 15Kg.
n=60 participants at risk
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 5Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
Atropine: IV dose at 5 mcg/kg
|
|---|---|
|
Cardiac disorders
asystole
|
0.00%
0/60 • 1 day
until the child is discharged from hospital on the day anesthesia was provided
|
|
Cardiac disorders
Bradycardia
|
0.00%
0/60 • 1 day
until the child is discharged from hospital on the day anesthesia was provided
|
Other adverse events
| Measure |
Children Less Than 15Kg.
n=60 participants at risk
This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 5Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.
Atropine: IV dose at 5 mcg/kg
|
|---|---|
|
Cardiac disorders
arrhythmias
|
0.00%
0/60 • 1 day
until the child is discharged from hospital on the day anesthesia was provided
|
Additional Information
Dr. Jerrold Lerman
Women and Children's Hospital of Buffalo, State University of New York at Buffalo
Phone: 7168787701
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place